IP Library Granted Patent US 11,730,929
Granted Patent B2
US 11,730,929 · App. 17/246,265 · Granted Aug 22, 2023

Methods and devices for treatment of stenosis of arteriovenous fistula shunts

Inventors: James B. Laudenslager (San Marcos, CA); Dean S. Irwin (Carlsbad, CA)
A61M25/09A61B18/245A61B50/30A61B2018/0041A61B2018/00285A61B2018/00577A61B2018/206A61B2018/2222A61B2018/2238A61B2050/314A61B2090/3966A61M25/002A61M2025/0177A61M2025/105
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,730,929
App. No.
17/246,265
Granted
Aug 22, 2023
Kind
B2
Abstract

Devices and methods are discussed directed to the use of a low profile laser ablation catheter for use in laser ablation removal of arterial plaque blockages to restore blood flow in the treatment of arteriovenous fistulas. Also discussed are devices and methods directed to packaging, long term storage and sterilization of liquid core ablation catheters.

Claims (16)

1. A liquid core ablation catheter, comprising:

a multi-layer catheter tube comprising:

a base layer tube comprising a fluoropolymer material,

an internal coating disposed on an inner surface of the base layer tube, the internal coating including an index of refraction,

an outer layer disposed on an outer surface of the base layer tube;

a first solid window that seals the inner lumen at a first end of the multi-layer catheter tube;

a second solid window that seals the inner lumen at a second end of the multi-layer catheter tube; and

a core liquid disposed within and completely filling the inner lumen of the multi-layer catheter tube, the core liquid including an index of refraction which is higher than the index of refraction of the internal coating and with the outer layer including a material that is impervious to diffusion of the core liquid.

2. The liquid core ablation catheter of claim 1 wherein the material of the outer layer that is impervious to diffusion of the core liquid comprises polychlorotrifluoroethylene.

3. The liquid core ablation catheter of claim 1 wherein the fluoropolymer material of the catheter tube comprises fluorinated ethylene propylene.

4. The liquid core ablation catheter of claim 1 further comprising a braided layer disposed over an outer surface of the base layer tube.

5. The liquid core ablation catheter of claim 1 wherein the internal coating on the inner surface of the base layer tube comprises an amorphous fluoropolymer.

6. The liquid core ablation catheter of claim 1 wherein the internal coating disposed on the inner surface of the base layer tube comprises a low index of refraction of less than about 1.34.

7. The liquid core ablation catheter of claim 1 wherein the base layer tube comprises a material that is impervious to diffusion of the core liquid disposed within the inner lumen of the multi-layer catheter tube.

8. The liquid core ablation catheter of claim 7 wherein the material of the base layer tube that is impervious to diffusion of the core liquid comprises polychlorotrifluoroethylene.

9. The liquid core ablation catheter of claim 1 wherein each of the first solid window and the second solid window comprises ultraviolet grade silica.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 11, 2022
From: LAUDENSLAGER, JAMES; IRWIN, DEAN S.
To: RA MEDICAL SYSTEMS, INC.
Reel/Frame 058624/0640 →
MERGER Recorded Jan 11, 2022
From: RA MEDICAL SYSTEMS, INC. (A CALIFORNIA CORPORATION)
To: RA MEDICAL SYSTEMS, INC. (A DELAWARE CORPORATION)
Reel/Frame 058624/0723 →
Continuity (5)
Continuation 16502766 · Jul 3, 2019
Continuation 15723062 · Oct 2, 2017
Division 14515435 · Oct 15, 2014
Provisional Application 61891830 · Oct 16, 2013
Related Publication 20210252258A1 · Aug 19, 2021